# FDA Inspection 1199913 - Octapharma Plasma Inc - March 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d7860e54-16f2-476d-a900-9cb37d90df91
Source feed: FDA_Inspections

> FDA Inspection 1199913 for Octapharma Plasma Inc on March 01, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199913
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-03-01
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1199913 - 2023-03-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/25c8c16b-ad9c-403d-bb53-093f434bd21d)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/101c6dc9-0dde-4bd2-9e25-7c8b5bb85421

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d